Essential Thrombocythemia | List of Frontiers open access articles

Original Research

Published on 30 Apr 2020

Platelet Toll-Like Receptors Mediate Thromboinflammatory Responses in Patients With Essential Thrombocythemia

in Inflammation

Cecilia P. Marín Oyarzún
Ana C. Glembotsky
Nora P. Goette
Paola R. Lev
Geraldine De Luca
María C. Baroni Pietto
Beatriz Moiraghi
Miguel A. Castro Ríos
Angeles Vicente
Rosana F. Marta

Frontiers in Immunology

doi 10.3389/fimmu.2020.00705

10,873 views
52 citations

Original Research

Published on 20 Dec 2022

Coagulation status and determinants of possible aspirin resistance in patients with essential thrombocythemia

in Hematology

Erpeng Yang
Yan Lv
Ziqing Wang
Dehao Wang
Yumeng Li
Yan Sun
Yanyu Zhang
Jicong Niu
Zhuo Chen
Weiyi Liu

Frontiers in Medicine

doi 10.3389/fmed.2022.1092281

3,539 views
5 citations

Original Research

Published on 23 May 2025

Downregulated PTEN and aberrant JAK–STAT signal pathway in essential thrombocythemia patients

in Blood Cancer

Lin Luo
Xiaoyan Liu
Hui Shen
Hao Zhang
Yufeng Shang
Xian Zhang
Donglei Zhang

Frontiers in Hematology

doi 10.3389/frhem.2025.1479185

1,688 views

Original Research

Published on 21 Dec 2021

Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World

in Hematologic Malignancies

Yingxin Sun
Yifeng Cai
Jiannong Cen
Mingqing Zhu
Jinlan Pan
Qian Wang
Depei Wu
Suning Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.797825

10,485 views
7 citations

Review

Published on 16 Feb 2021

Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia

in Hematologic Malignancies

Douglas Tremblay
Heidi E. Kosiorek
Amylou C. Dueck
Ronald Hoffman

Frontiers in Oncology

doi 10.3389/fonc.2020.636675

8,319 views
12 citations

Brief Research Report

Published on 04 Jan 2024

A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia

in Hematologic Malignancies

Zhuanghui Hao
Juan Li
Feng Gao
Weixiao Ren
Xiaomei Lu
Jinyi Feng
Chen Zhang
Sicheng Bian
Juan Xie
Ming Luo

Frontiers in Oncology

doi 10.3389/fonc.2023.1265022

3,908 views

Case Report

Published on 17 Sep 2021

Case Report: PRES-Like Syndrome With Reversible Cortical Blindness Associated With Essential Thrombocythemia

in Stroke

Ying Li
Yuanfeng Miao
Meng Yu
Ying Zhu
Zeyin Liang
Zhaoxia Wang
Qing Peng

Frontiers in Neurology

doi 10.3389/fneur.2021.743165

3,241 views
3 citations

Case Report

Published on 08 Jun 2023

Case Report: Effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy

in Hematologic Malignancies

Nupur Krishnan
Russell Price
Rouslan Kotchetkov

Frontiers in Oncology

doi 10.3389/fonc.2023.1213942

3,700 views
3 citations

Case Report

Accepted on 26 Feb 2026

Ruxolitinib Reverses Systemic Vasculitis Driven by JAK2 V617F–Mutated Essential Thrombocythemia: a case report

in Inflammation

Yutaro Ashida
Shinji Ota
Nao Ishidoya
Yasuhisa Murai
Kyoko Amenomori
Keisuke Hasui
Shogo Kawaguchi
Satoko Yamaguchi
Hiroto Hiraga
Kosuke Kamata

Frontiers in Immunology

Case Report

Accepted on 23 Jan 2026

Acute Mesenteric Vein Thrombosis and Small-Bowel Infarction Complicated by Essential Thrombocythemia: A case report

in Visceral Surgery

Xia Xu
Wenyan Liu
Huipeng Zhang
Yanbo Yu

Frontiers in Surgery

128 views

Original Research

Published on 21 Aug 2023

The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease’s phenotype

in Hematologic Malignancies

Patryk Sobieralski
Bartosz Wasąg
Aleksandra Leszczyńska
Monika Żuk
Maria Bieniaszewska

Frontiers in Oncology

doi 10.3389/fonc.2023.1224590

5,297 views
1 citation

Case Report

Published on 22 Nov 2022

Case report: Double L611S/V617L JAK2 mutation in a patient with polycythemia vera originally diagnosed with essential thrombocythemia

in Hematologic Malignancies

Xiao-qing Li
Jia-jun Liu
Cheng-cheng Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.937362

2,897 views
1 citation

Review

Published on 08 Sep 2023

BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing

in Cancer Genetics and Oncogenomics

Aleksandra Mroczkowska-Bękarciak
Tomasz Wróbel

Frontiers in Genetics

doi 10.3389/fgene.2023.1241912

7,120 views
6 citations

Case Report

Published on 01 Feb 2024

Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome

in Hematologic Malignancies

Leah Kogan
Russell Price
Rouslan Kotchetkov

Frontiers in Oncology

doi 10.3389/fonc.2024.1326209

3,187 views
2 citations

Perspective

Published on 22 May 2017

Calreticulin in Essential Thrombocythemia: StressINg OUT the Megakaryocyte Nucleus

in Hematologic Malignancies

Francisco Jose Iborra
Petros Papadopoulos

Frontiers in Oncology

doi 10.3389/fonc.2017.00103

6,929 views
2 citations

Case Report

Published on 25 Aug 2025

Carotid artery stenting in JAK2 V617F-positive essential thrombocythemia with symptomatic internal carotid artery stenosis: a case report

in Thrombosis and Haemostasis

Minghui Du
Yinbao Hu
Zhigang Liang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1658456

2,148 views

Articles

Platelet Toll-Like Receptors Mediate Thromboinflammatory Responses in Patients With Essential Thrombocythemia

Coagulation status and determinants of possible aspirin resistance in patients with essential thrombocythemia

Downregulated PTEN and aberrant JAK–STAT signal pathway in essential thrombocythemia patients

Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World

Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia

A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia

Case Report: PRES-Like Syndrome With Reversible Cortical Blindness Associated With Essential Thrombocythemia

Case Report: Effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy

Ruxolitinib Reverses Systemic Vasculitis Driven by JAK2 V617F–Mutated Essential Thrombocythemia: a case report

Acute Mesenteric Vein Thrombosis and Small-Bowel Infarction Complicated by Essential Thrombocythemia: A case report

The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease’s phenotype

Case report: Double L611S/V617L JAK2 mutation in a patient with polycythemia vera originally diagnosed with essential thrombocythemia

BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing

Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome

Calreticulin in Essential Thrombocythemia: StressINg OUT the Megakaryocyte Nucleus

Carotid artery stenting in JAK2 V617F-positive essential thrombocythemia with symptomatic internal carotid artery stenosis: a case report